Surgical palliation of pancreatic cancer

Cancer Journal (United States)

Volumn 18, Issue 6, 2012, Pages 577-583

  Conrad, Claudius ^a   Lillemoe, Keith D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

gastric outlet obstruction; obstructive jaundice; Pancreatic cancer; surgical palliation; tumor associated pain

Indexed keywords

CANCER PALLIATIVE THERAPY; CANCER SURGERY; ENDOSCOPIC ECHOGRAPHY; GASTROJEJUNOSTOMY; HUMAN; METAL STENT; NERVE BLOCK; OBSTRUCTIVE JAUNDICE; OPERATION DURATION; PAIN; PANCREAS CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF EXPANDING STENT; STOMACH EMPTYING; STOMACH OBSTRUCTION; TREATMENT INDICATION;

HUMANS; PALLIATIVE CARE; PANCREATIC NEOPLASMS;

EID: 84871196659     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3182797dfe     Document Type: Review

References (53)

1. World Health Organization's Pain Ladder. Surveillance Epidemiology End Results Stat Fact Sheets: Pancreas. Available at: http://seer.cancer. gov/statfacts/html/pancreas.html. Accessed October 13, 2012.
2. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237:74-85.
3. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcita-bine for metastatic pancreatic cancer. N Engl J Med. 2011;364: 1817-1825.
4. Hosein PJ, Macintyre J, Kawamura C, et al. A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma. BMC Cancer. 2012;12:199.
5. Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302:741-749.
6. Ali AS, Ammori BJ. Concomitant laparoscopic gastric and biliary bypass and bilateral thoracoscopic splanchnotomy: the full package of minimally invasive palliation for pancreatic cancer. Surg Endosc. 2003;17:2028-2031.
7. Date RS, Siriwardena AK. Laparoscopic biliary bypass and current management algorithms for the palliation of malignant obstructive jaundice. Ann Surg Oncol. 2004;11:815-817.
8. Date RS, Siriwardena AK. Current status of laparoscopic biliary bypass in the management of non-resectable peri-ampullary cancer. Pancrea-tology. 2005;5:325-329.
9. Kazanjian KK, Reber HA, Hines OJ. Laparoscopic gastrojejunostomy for gastric outlet obstruction in pancreatic cancer. Am Surg. 2004;70: 910-913.
10. Bucher P, Pugin F, Morel P. Transumbilical single-incision laparoscopic intracorporeal anastomosis for gastrojejunostomy: case report. Surg Endosc. 2009;23:1667-1670.
11. Buchs NC, Addeo P, Bianco FM, et al. Robotic palliation for unresect-able pancreatic cancer and distal cholangiocarcinoma. Int J Med Robot. 2011;7:60-65.
12. Venkat R, Edil BH, Schulick RD, et al. Laparoscopic distal pancreatec-tomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg. 2012;255:1048-1059.
13. Jayaraman S, Gonen M, Brennan MF, et al. Laparoscopic distal pancre-atectomy: evolution of a technique at a single institution. J Am Coll Surg. 2010;211:503-509.
14. Kooby DA, Gillespie T, Bentrem D, et al. Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg. 2008;248:438-446.
15. House MG, Lillemoe KD. Palliative therapy for pancreatic cancer. In: Cameron JL, ed. Current Surgical Therapy. 8th ed. St Louis, MO: Mosby Inc; 2004:504-510.
16. Yeo CJ. Pancreatic cancer: 1998 update. J Am Coll Surg. 1998;187: 429-442.
17. Koninger J, Wente MN, Muller MW, et al. Surgical palliation in patients with pancreatic cancer. Langenbecks Arch Surg. 2007;392:13-21.
18. Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc. 2002;56:835-841.
19. Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastroje-junostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg. 1999;230:322-328.
20. Van Heek NT, De Castro SM, van Eijck CH, et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg. 2003;238:894-902.
21. Heinicke JM, Buchler MW, Laffer UT. Bilio-digestive double bypass for nonresectable pancreatic cancer. Dig Surg. 2002;19:165-167.
22. Kuhlmann KF, de Castro SM, Wesseling JG, et al. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer. 2004;40:549-558.
23. http://www.who.int/cancer/palliative/painladder/en/.
24. Cruciani RA, Jain S. Pancreatic pain: a mini review. Pancreatology. 2008;8:230-235.
25. Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2006;3:CD006146.
26. Arcidiacono PG, Calori G, Carrara S, et al. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011; 3:CD007519.
27. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg. 1995; 80:290-295.
28. Lillemoe KD, Cameron JL, Kaufman HS, et al. Chemical splanchni-cectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg. 1993;217:447-455.
29. Kelsen DP, Portenoy R, Thaler H, et al. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery. 1997;122: 53-59.
30. Smith AC, Dowsett JF, Russell RC, et al. Randomised trial of endoscop-ic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet. 1994;344:1655-1660.
31. Speer AG, Cotton PB, Russell RC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987;2:57-62.
32. Arguedas MR, Heudebert GH, Stinnett AA, et al. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am J Gastroenterol. 2002;97:898-904.
33. Telford JJ, Carr-Locke DL, Baron TH, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72:907-914.
34. Kullman E, Frozanpor F, Soderlund C, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72:915-923.
35. Chen VK, Arguedas MR, Baron TH. Expandable metal biliary stents before pancreaticoduodenectomy for pancreatic cancer: a Monte-Carlo decision analysis. Clin Gastroenterol Hepatol. 2005;3: 1229-1237.
36. DiFonozo LA, Cymerman J, Egrari S, et al. Unresectable pancreatic carcinoma: correlating length if survival with choice of palliative bypass. Am Surg. 1999;65:9558.
37. Sarfeh IJ, Ryptins EB, Jakowatz JG, et al. A prospective, randomized clinical investigation of cholecystoenterostomy and choledochoenter-ostomy. Am J Surg. 1988;155:411-414.
38. Urbach DR, Bell CM, Swanstrom LL, et al. Cohort study of surgical bypass to the gallbladder or bile duct for the palliation of jaundice due to pancreatic cancer. Ann Surg. 2003;237:86-93.
39. Sohn TA, Lillemoe KD, Cameron JL, et al. Surgical palliation of unre-sectable periampullary adenocarcinoma in the 1990's. J Am Coll Surg. 1999;188:658-666.
40. Telford JJ, Carr-Locke DL, Baron TH, et al. Palliation of patients with malignant gastric outlet obstruction with the enteral wall stent: outcomes from a multicenter study. Gastrointest Endosc. 2004;60: 916-920.
41. Jeurnink SM, van Eijck CH, Steyerberg EW, et al. Stent versus gastro-jejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol. 2007;8:18.
42. Fiori E, Lamazza A, Volpino P, et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 2004;24: 269-271.
43. Meha S, Hindmarsh A, Cheong E, et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc. 2006;20:239-242.
44. Hosono S, Ohtani H, Arimoto Y, et al. Endoscopic stenting versus surgical gastroenterostomy for palliation of malignant gastroduodenal obstruction: a meta-analysis. J Gastroenterol. 2007;42:283-290.
45. Lo SK. Endoscopic palliation of pancreatic cancer. Gastroenterol Clin North Am. 2012;41:237-253.
46. Wong GY, Schroeder DR, Carns PE, et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA. 2004;291:1092-1099.
47. Davies DD. Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med. 1993;86:264-266.
48. Noble M, Gress FG. Techniques and results of neurolysis for chronic pancreatitis and pancreatic cancer pain. Curr Gastroenterol Rep. 2006;8:99-103.
49. Sakamoto H, Kitano M, Komaki T, et al. Endoscopic ultrasoundY guided neurolysis in pancreatic cancer. Pancreatology. 2011;11:52-58.
50. Kaufman M, Singh G, Das S, et al. Efficacy of endoscopic ultrasoundY guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44:127-134.
51. LeBlanc JK, Al-Haddad M, McHenry L, et al. A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two? Gastrointest Endosc. 2011;74:1300-1307.
52. Gillen S, Schuster T, Friess H, et al. Palliative resections versus palliative bypass procedures in pancreatic cancerVa systematic review. Am J Surg. 2012;203:496-502.
53. Walter J, Nier A, Rose T, et al. Palliative partial pancreaticoduodenec- tomy impairs quality of life compared to bypass surgery in patients with advanced adenocarcinoma of the pancreatic head. Eur J Surg Oncol. 2011;37:798-804.